Previous 10 | Next 10 |
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes that Both Regulatory and Commercial Milestones to be Achieved in Accordance with the Company’s Current Timeline BRAINTREE,...
2024-02-20 16:52:00 ET More on Microbot Medical Microbot Medical announces settlement resolving legal matters Microbot Medical down 22%, exercises investment options for $2.73M proceeds Read the full article on Seeking Alpha For further details see: Micro...
2024-02-05 12:11:35 ET More on Microbot Medical Microbot Medical announces settlement resolving legal matters Microbot Medical down 22%, exercises investment options for $2.73M proceeds Seeking Alpha’s Quant Rating on Microbot Medical Historical earnin...
BRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the LIBERTY ® Endovascular Robotic Surgical System, announced that it has filed an Investigational Device Exemption (IDE) application with the US Food and Drug Administration (FDA). The...
2024-01-30 07:29:59 ET More on Microbot Medical Microbot Medical down 22%, exercises investment options for $2.73M proceeds Microbot to advance Liberty Robotic System into pivotal clinical trial Seeking Alpha’s Quant Rating on Microbot Medical Historic...
BRAINTREE, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announced it has signed a Settlement Agreement and Release with Empery Asset Master Ltd., Empery Tax Efficient, LP, ...
BRAINTREE, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announced that following the recent positive results of its pivotal GLP Pre-Clinical Study, and to support its antic...
2024-01-12 16:22:07 ET More on Microbot Medical Microbot Medical down 22%, exercises investment options for $2.73M proceeds Microbot to advance Liberty Robotic System into pivotal clinical trial For further details see: Microbot Medical files to sell 1.77M shares...
2023-12-29 08:28:03 ET More on Microbot Medical Microbot to advance Liberty Robotic System into pivotal clinical trial Seeking Alpha’s Quant Rating on Microbot Medical Historical earnings data for Microbot Medical Financial information for Microbot Med...
2023-12-29 08:21:40 ET Microbot Medical ( MBOT ) -27% after announces exercise of outstanding preferred investment options for $2.73 million. Ucommune International ( UK ) -21% . SenesTech ( SNES ) -20% . Cingulate ( CING ) -20% . Bone B...
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
BRAINTREE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board (IRB) approval and signed a clinical trial agreement with Memor...
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular R...
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular Robotic Surgical System BRAINTREE, Mass., July 08, 2024 (G...